# Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer

> **NCT05976412** · NA · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 1355 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Regional lymph node radiotherapy
- **RADIATION:** chest/whole breast irradiation

## Key facts

- **NCT ID:** NCT05976412
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-28
- **Primary completion:** 2031-05-31
- **Final completion:** 2031-05-31
- **Target enrollment:** 1355 (ESTIMATED)
- **Last updated:** 2023-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05976412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05976412, "Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05976412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*